• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Inhalation Sciences Sweden

0.20 SEK

-4.41 %

Less than 1K followers

ISAB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-4.41 %
-28.83 %
-17.37 %
-59.38 %
-50.76 %
-66.38 %
-92.29 %
-97.82 %
-97.64 %

Inhalation Sciences Sweden, ISAB, is a research company. The company focuses primarily on the production and development of laboratory instruments. The instruments are used to measure particles in inhaled air and how the composition of the air affects the lungs. The company sells products under various brands, mainly on the European market. Inhalation Sciences Sweden was founded in 2004 and is headquartered in Huddinge.

Read more
Market cap
9.98M SEK
Turnover
25.76K SEK
Revenue
3.04M
EBIT %
-333.94 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
17/6
2026

General meeting '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release5/29/2026, 6:15 AM

Inhalation Sciences Sweden AB (publ): uppdatering avseende pågående processer

Inhalation Sciences Sweden
Regulatory press release5/27/2026, 11:44 AM

Inhalation Sciences Sweden AB (publ): Kompletterande information avseende revisorsanmärkning i årsredovisningen 2025

Inhalation Sciences Sweden
Regulatory press release5/27/2026, 11:00 AM

Inhalation Sciences Sweden AB (publ) publicerar årsredovisning för 2025

Inhalation Sciences Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/18/2026, 8:10 AM

Inhalation Sciences receives IRS order worth approximately EUR 117,000

Inhalation Sciences Sweden
Regulatory press release5/15/2026, 7:00 AM

Inhalation Sciences: KALLELSE TILL ÅRSSTÄMMA I INHALATION SCIENCES SWEDEN AB (PUBL)

Inhalation Sciences Sweden
Regulatory press release5/11/2026, 6:30 AM

Inhalation Sciences AB (publ) publicerar delårsrapport för det första kvartalet 2026

Inhalation Sciences Sweden
Regulatory press release4/2/2026, 11:38 AM

Inhalation Sciences riktade emission är registrerad på Bolagsverket

Inhalation Sciences Sweden
Press release3/24/2026, 3:30 PM

Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000

Inhalation Sciences Sweden
Regulatory press release3/19/2026, 12:00 PM

Kommuniké från extra bolagsstämma i Inhalation Sciences

Inhalation Sciences Sweden
Regulatory press release3/10/2026, 9:10 AM

Inhalation Sciences optionsinlösen är registrerad hos Bolagsverket och interimsaktier omvandlas till aktier

Inhalation Sciences Sweden
Regulatory press release3/3/2026, 7:00 AM

Inhalation Sciences: KALLELSE TILL EXTRA BOLAGSSTÄMMA I INHALATION SCIENCES SWEDEN AB (PUBL)

Inhalation Sciences Sweden
Regulatory press release3/2/2026, 6:10 PM

Inhalation Sciences tillförs 2,88 MSEK i samband med optionsinlösen och garantiåtagande för teckningsoptioner av serie TO2

Inhalation Sciences Sweden
Regulatory press release2/27/2026, 7:30 AM

Inhalation Sciences AB (publ) publicerar bokslutskommuniké 2025

Inhalation Sciences Sweden
Regulatory press release2/18/2026, 8:10 AM

Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000

Inhalation Sciences Sweden
Regulatory press release2/13/2026, 7:30 AM

Inhalation Sciences meddelar att nyttjandeperioden för teckningsoptioner av serie TO2 inleds idag till fastställd kurs 0,24 kr och att teckningsoptionsinlösen är fullt garanterad

Inhalation Sciences Sweden
Press release1/27/2026, 11:50 AM

Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies

Inhalation Sciences Sweden
Regulatory press release12/22/2025, 7:30 AM

Inhalation Sciences receives major IRS order for DissolvIt® from leading global pharma company

Inhalation Sciences Sweden
Press release12/11/2025, 7:30 AM

Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference

Inhalation Sciences Sweden
Regulatory press release12/4/2025, 10:20 AM

Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market

Inhalation Sciences Sweden
Regulatory press release11/21/2025, 7:30 AM

Inhalation Sciences AB (publ) publicerar delårsrapport för det tredje kvartalet 2025

Inhalation Sciences Sweden